1. Home
  2. RDNT vs DNB Comparison

RDNT vs DNB Comparison

Compare RDNT & DNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDNT
  • DNB
  • Stock Information
  • Founded
  • RDNT 1985
  • DNB 1841
  • Country
  • RDNT United States
  • DNB United States
  • Employees
  • RDNT N/A
  • DNB N/A
  • Industry
  • RDNT Medical Specialities
  • DNB Finance: Consumer Services
  • Sector
  • RDNT Health Care
  • DNB Finance
  • Exchange
  • RDNT Nasdaq
  • DNB Nasdaq
  • Market Cap
  • RDNT 5.9B
  • DNB 5.6B
  • IPO Year
  • RDNT 1986
  • DNB 2020
  • Fundamental
  • Price
  • RDNT $81.98
  • DNB $12.34
  • Analyst Decision
  • RDNT Strong Buy
  • DNB Buy
  • Analyst Count
  • RDNT 4
  • DNB 7
  • Target Price
  • RDNT $74.75
  • DNB $13.83
  • AVG Volume (30 Days)
  • RDNT 590.7K
  • DNB 3.5M
  • Earning Date
  • RDNT 11-10-2024
  • DNB 10-31-2024
  • Dividend Yield
  • RDNT N/A
  • DNB 1.63%
  • EPS Growth
  • RDNT N/A
  • DNB N/A
  • EPS
  • RDNT N/A
  • DNB N/A
  • Revenue
  • RDNT $1,772,946,000.00
  • DNB $2,380,200,000.00
  • Revenue This Year
  • RDNT $12.83
  • DNB $5.10
  • Revenue Next Year
  • RDNT $8.66
  • DNB $4.77
  • P/E Ratio
  • RDNT N/A
  • DNB N/A
  • Revenue Growth
  • RDNT 12.20
  • DNB 4.46
  • 52 Week Low
  • RDNT $32.00
  • DNB $8.78
  • 52 Week High
  • RDNT $93.65
  • DNB $12.75
  • Technical
  • Relative Strength Index (RSI)
  • RDNT 66.81
  • DNB 63.07
  • Support Level
  • RDNT $77.34
  • DNB $11.86
  • Resistance Level
  • RDNT $93.65
  • DNB $12.75
  • Average True Range (ATR)
  • RDNT 3.22
  • DNB 0.26
  • MACD
  • RDNT 0.64
  • DNB 0.01
  • Stochastic Oscillator
  • RDNT 58.24
  • DNB 64.41

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.

About DNB Dun & Bradstreet Holdings Inc.

Dun & Bradstreet Holdings Inc is a provider of business decisioning data and analytics. The company operates in two segments: North America, which offers Finance & Risk and Sales & Marketing data, analytics, and business insights in the United States and Canada; and International, which offers Finance & Risk and Sales & Marketing data, analytics, and business insights directly in the U.K, Europe, Greater China, India and indirectly through its WWN alliances. The company generates maximum revenue from the North American region. Other services provided by the company include digital marketing, sales acceleration, and risk management among others.

Share on Social Networks: